Clinical Trial Update: A Study of Istradefylline (KW-6002) in Treating Patients With Parkinson's Disease on Levodopa [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating istradefylline as an add-on therapy for Parkinson's disease in patients on levodopa has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• istradefylline (istradefylline)

Snippet

Sponsor: Kyowa Kirin, Inc. | Conditions: Parkinson's Disease | Phase 3 | Status: COMPLETED